검색
Onconetix Inc
ONCO관심 목록에 추가
0.639USD
-0.025-3.77%
종가 09-18 16:00（ET）
2.49M시가총액
0.00P/E TTM
자세한 내용은 Onconetix Inc 회사
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
Onconetix Inc 프로필
종목 코드 ONCO
회사 이름Onconetix Inc
상장일Feb 18, 2022
CEOFedasz (Karina M)
직원 수5
유형Ordinary Share
회계 연도 종료Feb 18
주소201 E. Fifth Street
도시CINCINNATI
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호45202
전화15136204101
웹사이트https://www.onconetix.com/
종목 코드 ONCO
상장일Feb 18, 2022
CEOFedasz (Karina M)
Onconetix Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Simon Tarsh
Mr. Simon Tarsh
Independent Director
Independent Director
132.00
-6.06%
Mr. Simon Tarsh
Mr. Simon Tarsh
Independent Director
Independent Director
132.00
-6.06%
Ms. Karina M. Fedasz
Ms. Karina M. Fedasz
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. David Allan White
Mr. David Allan White
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Sammy Dorf, Esq.
Mr. Sammy Dorf, Esq.
Chairman of the Board
Chairman of the Board
--
--
Mr. Joshua A. (Josh) Epstein
Mr. Joshua A. (Josh) Epstein
Director
Director
--
--
Mr. Timothy R. Ramdeen
Mr. Timothy R. Ramdeen
Independent Director
Independent Director
--
--
Dr. Thomas Meier, Ph.D.
Dr. Thomas Meier, Ph.D.
Independent Director
Independent Director
--
--
Ms. Karina M. Fedasz
Ms. Karina M. Fedasz
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Andrew J. Oakley
Mr. Andrew J. Oakley
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Simon Tarsh
Mr. Simon Tarsh
Independent Director
Independent Director
132.00
-6.06%
Mr. Simon Tarsh
Mr. Simon Tarsh
Independent Director
Independent Director
132.00
-6.06%
Ms. Karina M. Fedasz
Ms. Karina M. Fedasz
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. David Allan White
Mr. David Allan White
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Sammy Dorf, Esq.
Mr. Sammy Dorf, Esq.
Chairman of the Board
Chairman of the Board
--
--
Mr. Joshua A. (Josh) Epstein
Mr. Joshua A. (Josh) Epstein
Director
Director
--
--
자주 묻는 질문
Onconetix Inc의 상위 5대 주주는 누구인가요?
Onconetix Inc의 상위 5대 주주는 다음과 같습니다: Mr. Simon Tarsh
Onconetix Inc(ONCO)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Onconetix Inc의 주식을 보유한 기관은 총 29곳이며, 이들이 보유한 주식의 총 가치는 약 26.70K로 전체 발행 주식의 3.85%를 차지합니다. 이는 2025Q4 대비 2185.00 증가한 수치입니다.